File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Fighting cancers from within: Augmenting tumor immunity with cytokine therapy

TitleFighting cancers from within: Augmenting tumor immunity with cytokine therapy
Authors
Issue Date2010
Citation
Trends in Pharmacological Sciences, 2010, v. 31, n. 8, p. 356-363 How to Cite?
AbstractThe human immune system has successfully evolved to fight many pathogens. Through vaccination, we can harness and improve immune responses to eradicate infections. Despite this success, we are only now beginning to understand the natural tumor immune surveillance mechanisms and why, in some instances, our immune system fails to abrogate the development and growth of tumors. Encouraging results with the latest immunotherapies have renewed enthusiasm in the field. A central component of these therapies is the contribution of cytokines. Here we review our expanding knowledge of cytokine-induced effects as well as preclinical and clinical data that indicate adjuvant cytokine therapies may hold much promise in improving anti-tumor immunity. Further studies on optimal synergistic combinations, timing, duration and additional adjuvant therapies are required to realize the full potential of cytokines as immunotherapeutic agents. © 2010 Elsevier Ltd.
Persistent Identifierhttp://hdl.handle.net/10722/292205
ISSN
2023 Impact Factor: 13.9
2023 SCImago Journal Rankings: 3.232
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorPellegrini, Marc-
dc.contributor.authorMak, Tak W.-
dc.contributor.authorOhashi, Pamela S.-
dc.date.accessioned2020-11-17T14:55:59Z-
dc.date.available2020-11-17T14:55:59Z-
dc.date.issued2010-
dc.identifier.citationTrends in Pharmacological Sciences, 2010, v. 31, n. 8, p. 356-363-
dc.identifier.issn0165-6147-
dc.identifier.urihttp://hdl.handle.net/10722/292205-
dc.description.abstractThe human immune system has successfully evolved to fight many pathogens. Through vaccination, we can harness and improve immune responses to eradicate infections. Despite this success, we are only now beginning to understand the natural tumor immune surveillance mechanisms and why, in some instances, our immune system fails to abrogate the development and growth of tumors. Encouraging results with the latest immunotherapies have renewed enthusiasm in the field. A central component of these therapies is the contribution of cytokines. Here we review our expanding knowledge of cytokine-induced effects as well as preclinical and clinical data that indicate adjuvant cytokine therapies may hold much promise in improving anti-tumor immunity. Further studies on optimal synergistic combinations, timing, duration and additional adjuvant therapies are required to realize the full potential of cytokines as immunotherapeutic agents. © 2010 Elsevier Ltd.-
dc.languageeng-
dc.relation.ispartofTrends in Pharmacological Sciences-
dc.titleFighting cancers from within: Augmenting tumor immunity with cytokine therapy-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.tips.2010.05.003-
dc.identifier.pmid20561689-
dc.identifier.scopuseid_2-s2.0-77955280009-
dc.identifier.volume31-
dc.identifier.issue8-
dc.identifier.spage356-
dc.identifier.epage363-
dc.identifier.isiWOS:000281176700003-
dc.identifier.issnl0165-6147-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats